Design of synthetic peptidic constructs for the vaccine development against viral infections

Current Protein and Peptide Science

Volumn 5, Issue 6, 2004, Pages 425-433

  Haro, Isabel ^a   Gómara, María José ^a  

^a DEPARTMENT OF ENVIRONMENTAL CHEMISTRY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; CYCLOPEPTIDE; CYTOMEGALOVIRUS VACCINE; DENDRIMER; FATTY ACID; FOOT AND MOUTH DISEASE VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; HEPATITIS C VACCINE; HERPES SIMPLEX VACCINE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; LIPOPEPTIDE; LIPOSOME; LIVE VACCINE; MEASLES VACCINE; MONOCLONAL ANTIBODY; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE; NEUTRALIZING ANTIBODY; NEW DRUG; OLIGOSACCHARIDE; POLYGLACTIN; RESPIRATORY SYNCYTIAL VIRUS VACCINE; SYNTHETIC PEPTIDE; TRIPALMITOYLGLYCERYLCYSTEINYLSERYLSERINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRUS DNA; VIRUS VACCINE;

CHEMICAL MODIFICATION; COVALENT BOND; CYTOMEGALOVIRUS INFECTION; DNA RECOMBINATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; FOOT AND MOUTH DISEASE; HEPATITIS A; HEPATITIS B; HEPATITIS C; HERPES SIMPLEX; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOGENICITY; INFLUENZA; INFLUENZA VACCINATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEASLES; MEASLES VACCINATION; NONHUMAN; PESTIVIRUS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; VACCINATION; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS MENINGITIS; VIRUS RECOMBINANT; WART VIRUS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS; DRUG CARRIERS; DRUG DESIGN; HUMANS; IMMUNIZATION; PEPTIDES; VACCINES, SUBUNIT; VACCINES, SYNTHETIC; VIRUS DISEASES;

EID: 9244230030     PISSN: 13892037     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389203043379314     Document Type: Review

References (106)

1. Zauner, W., Lingnau, K., Mattner, F., VonGabain, A. and Buschle, M. (2001) Biol. Chem., 382, 581-595.
2. El Kasmi, K. and Muller, C.P. (2001) Vaccine, 19, 2238-2244.
3. Lopez, J.A., Weilenman, C., Audran, R., Roggero, M.A., Bonelo. A., Tiercy, J.M., Spertini, F. and Corradin, G. (2001) Eur. J. Immunol., 31, 1989-1998.
4. Demotz, S., Moulon, C., Roggero, M.A., Fasel, N. and Masina, S. (2001) Mol. Immunol., 38, 415-422.
5. Arnon, R. and Ben-Yedidia, T. (2003) International Immunopharmacology, 3, 1195-1204.
6. Van Regenmortel, M.H.V. (2001) Vaccine, 19, 2369-2374.
7. Oomen, C.J., Hoogerhout, P., Bonvin, A.M.J.J., Kuipers, B., Brugghe, H., Timmermans, H., Haseley, S.R., Alphen, L. and Gros, P. (2003) J. Mol. Biol., 328, 1083-1089.
8. Meloen, R.H., Langeveld, J.P.M., Schaaper, W.M.M. and Slootstra, J.W. (2001) Biologicals, 29, 233-236.
9. Celis, E. (2002) J Clin. Invest., 110, 1765-1768.
10. Lairmore, M.D., DiGeorge, A.M., Conrad, S.F., Trevino, A.V., Lal, R.B. and Kaumaya, P.T.P. (1995) J. Virol., 69, 6077-6089.
11. Frangione-Beebe, M., Albrecht, B., Dakappagati, N., Rose, T., Brooks, C.L., Schwendeman, S.P., Lairmore, M.D. and Kaumaya, P.T.P. (2001) Vaccine, 19, 1068-1081.
12. Partidos, C., Stanley, C. and Steward, M. (1992) Eur. J Immunol., 22, 2675-80.
13. Partidos, C., Stanley, C. and Steward, M. (1992) Mol. Immunol., 29, 651-658.
14. Muller, S. (1999) in Synthetic Peptides as Antigens (Van Regenmortel, M.H.V. and Muller, S., Eds.). pp. 133-177. Elsevier, Amsterdam.
15. Pintó, R.M., González-Dankaart, J.F., Sánchez, G., Guix, S., Gómara, M.J., García, M., Haro, I. and Bosch, A. (1998) FEBS Lett., 438, 106-110.
16. Cox, J.H., Ivanyi, J., Young, D.B., Lamb, J.R., Syred, A.D. and Francis, M.J. (1988) Eur. J. Immunol., 18, 2015-2019.
17. Ahlborg, N., Nardin, E.H., Perlmann, P., Berzins, K. and Andersson, R. (1998) Vaccine, 16, 38-44.
18. Zeng, W., Ghosh, S., Macris, M., Pagnon, J. and Jackson, D.C. (2001) Vaccine, 19, 3843-3852.
19. Olive, C., Toth, I. and Jackson, D. (2001) Mini. Rev. Med. Chem., 1, 429-438.
20. Tam, J.P. (1998) Proc. Natl. Acad. Sci. USA, 85, 5409-5413.
21. Nardin, E.H., Oliveira, G.A., Calvo-Calle, J.M. and Nussenzweig, R.S. (1995) Adv. Immunol., 60, 105-149.
22. Sadler, K. and Tam, J.P. (2002) Rev. Mol. Biotechnol., 90, 195-229.
23. Mozdzanowska, K., Feng, J., Eid, M., Kragol, G., Cudic, M., Otvos, L. and Gerhard, W. (2003) Vaccine, 21, 2616-2626.
24. Steward, M.W. (2001) Biologicals, 29, 215-219.
25. Cabezas, E., Wang, M., Parren, P.W.H.I., Stanfield, R.L. and Satterthwait, A.C. (2000) Biochemistry, 39, 14377-14391.
26. Davies, J.S. (2003) J. Peptide Sci., 9, 471-501.
27. Lambert, J.N., Mitchell, J.P. and Roberts, K.D. (2001) J. Chem. Soc. Perkin I., 471-484.
28. Spatola, A. and Romanovskis, P. (2000) In: The amide linkage: selected structural aspects in chemistry, biochemistry and material science (Greenberg, A., Breneman, C. and Liebman, J.F., Eds . pp. 519-564. Wiley, Chichester.
29. Mellor, S.L., Welling, D.A., Fehrentz, J.A., Paris, M., Martinez, J., Ede, N.J., Bray, A.M., Evans, D.J., Bloomberg, G.B. (2000) In Fmoc Solid Phase Peptide Synthesis: a practical approach (Chan, W.C. and White, P.D., Eds). pp. 172-178. Oxford University Press, Oxford.
30. Misumi, S., Endo, M., Mukai, R., Tachibana, K., Umeda, M., Honda, T., Takamine, N. and Shoji, S. (2003) J. Biol. Chem., 34 32335-32343.
31. MacGaughey, G.B., Citron, M., Danzeisen, R.C., Freidinger, R.M., Garsky, V.M., Hurni, W.M., Joyce, J.G., Liang, X., Miller, M., Shiver, J. and Bogusky, M.J. (2003) Biochemistry, 42, 3214-3223.
32. Engler, O.B., Juan Dai, W., Sette, A., Hunziker, I.P., Reichen, J., Pichler, W.J. and Cerny, A. (2001) Mol. Immunol., 38, 457-465.
33. Chisari, F.V. and Ferrari, C. (1995) Annu. Rev. Immunol., 13, 29-60.
34. Byrne, J.A. and Oldstone, M.B. (1984) J. Virol., 51 681-686.
35. Nardelli, B. and Tam, J.P. (1993) Immunology, 79, 355-361.
36. Mora, A and Tam, J. (1998) J. Immunol., 161, 3616-3623.
37. Nardin, E.H., Calvo-Calle, J.M., Oliveira, G.A., Nussenzweig, R.S., Schneider, M., Tiercy, J.M., Loutan, L., Hochstrasser, D. and Rose, K. (2001) J. Immunol., 166, 481-489.
38. Uhl, B., Speth, V., Wolf, B., Jung, G., Bessler, W.G. and Hauschildt, S. (1992) Eur. J. Cell. Biol., 58, 90-98.
39. BenMohamed, L., Wechsler, S.L. and Nesburn, A.B. (2002) The Lancet Infectious Diseases, 2, 425-431.
40. Tsunoda, I., Sette, A., Fujinami, R.S., Oseroff, C., Ruppert, J., Dahlberg, C., Southwood, S., Arrhenius, T., Kuang, L.Q., Kubo, R.T., Chesnut, R.W. and Ishioka, G.Y. (1999) Vaccine, 17, 675-685.
41. Hosmalin, A., Andrieu, M., Loing, E., Desoutter, J.F., Hanou, D., Gras-Masse, H., Dautry-Varsat, A. and Guillet, J.F. (2001) Immunol. Lett., 79, 97-100.
42. Andrieu, M., Desoutter, J.F., Loing, E., Gaston, J., Hanau, D., Guillet, J.G. and Hosmalin, A. (2003) J. Virol., 77, 1564-1570.
43. Loing, E., Thiam, K., Andrieu, M., Schörner, D., Wiesmüller, K.H., Hosmalin, A., Jung, G. and Gras-Masse, H. (2000) J. Immunol., 164, 900-907.
44. Gras-Masse, H. (2001) Mol. Immunol., 38, 423-431.
45. Benmohamed, L., Krishnan, R., Auge, C. and Primus, J.F. (2002) Immunology, 106, 113-121.
46. Benmohamed, L., Belkaid, Y., Loing, E., Brahimi, K., Gras-Masse, H. and Druilhe, P. (2002) Eur. J. Immunol., 32, 2274-2281.
47. Allison, A.C. (1997) Arch. Immunol. Ther. Exp., 45 141-147.
48. O'Hagan, D.T., MacKichan, M.L. and Singh, M. (2001) Biomolecular Engineering, 18, 69-78.
49. Gupta, R.K. and Siber, G.R. (1995) Vaccine, 13, 1263-1276.
50. Moynihan, J.S., Jones, D.H., Farrar, G.H. and Howard, C.R. (2001) Vaccine, 19, 3292-3300.
51. Kersten, G.F.A., Donders, D., Akkermans, A. and Beuvery, E.C. (1996) Vaccine, 14, 1627-1632.
52. Moynihan, J.S., Blair, J., Coombes, A., D'Mello, F. and Howard, C.R. (2002) Vaccine, 20, 1870-1876.
53. Allison, A.C. and Gregoriadis, G. (1974) Nature, 252 252.
54. Alving, C.R. (1991) J. Immunol. Methods, 140, 1-13.
55. Kovacsovics-Bankowski, M., and Rock, K.L. (1995) Science, 267, 243-246.
56. Kersten, G.F.A. and Crommelin, D.J.A. (1995) Biochim. Biophys. Acta, 1241, 117-138.
57. Chikh, G. and Schutze-Redelmeier, M.P. (2002) Biosci. Rep., 22, 339-353.
58. Ninomiya, A., Ogasawara, K., Kajino, K., Takada, A. and Kida, H. (2002) Vaccine, 20, 3123-3129.
59. Kriahnan, L., Dicaire, C.J., Patel, G.B. and Sprott, G.D. (2000) Infect. Immun., 68, 54-63.
60. Conlan, J.W., Krishnan, L., Willick, G.E., Patel, G.B. and Sprott, G.D. (2001) Vaccine, 19, 3509-3517.
61. Wiley, D.C. and Skehel, J.J. (1987) Annu. Rev. Biochem., 56, 365-394.
62. Ennis, F.A., Cruz, J., Jameson, J., Klein, M., Burt, D. and Thipphawong, J. (1999) Vaccine, 259, 256-261.
63. Le, T.T.T., Drane, D., Malliaros, J., Cox, J.C., Rothel, L., Pearse, M., Woodberry, T., Gardner, J. and Suhrbier, A. (2001) Vaccine, 19, 4669-4675.
64. Matlin, K.S., Reggio, H., Helenius, A. and Simons, K. (1981) J. Cell. Biol., 91, 601-613.
65. Cryz, S.J., Que, J.U. and Glueck, R. (1996) Vaccine, 14, 1381-1383.
66. Hunziker, I.P., Zurbriggen, R., Glueck, R., Engler, O.B., Reichen, J., Dai, W.J., Pichler, W.J. and Cerny, A. (2001) Mol. Immunol., 38, 475-484.
67. Hopp, T.P. (1984) Mol. Immunol., 1, 13-16.
68. Nardelli, B., Lu, Y.A., Shiu, DR., Delpierre-Defoort, C., Profy, A.T. and Tam, J.P. (1992) J. Immunol., 148, 914-920.
69. Nardelli, B., Haser, P.B. and Tam, J.P. (1994) Vaccine, 12, 1335-1339.
70. De Oliveira, E., Villen, J., Giralt, E. and Andreu, D. (2003) Bioconjug. Chem., 14, 144-152.
71. Defoort, J.P., Nardelli, B., Huang, W. and Tam, J.P. (1992) Int. J. Peptide Prot. Res., 40, 214-221.
72. Defoort, J.P., Nardelli, B., Huang, W., Ho, D.D. and Tam, J.P. (1992) Proc. Natl. Acad. Sci. USA, 89, 3879-3883.
73. Haro, I., Pérez, S., García, M., Chan, W.C. and Ercilla, G. (2003) FEBS Lett., 540, 133-140.
74. Moynihan, J.S., D'Mello, F.I.M. and Howard, C.R. (2000) J. Med. Virol., 62, 159-166.
75. Guan, X.J., Guan, X.J., Wu, Y.Z., Jia, Z.C., Shi, T.D. and Tang, Y. (2002) World J. Gastroenterol., 8, 294-297.
76. Chua, B.Y., Healy, A., Cameron, P.U., Stock, O., Rizkalla, M., Zeng, W., Torresi, J., Brown, L.E., Fowler, N.L., Gowans, E.J. and Jackson D.C. (2003) Immunol. Cell. Biol., 81, 67-72.
77. Sundaram, R., Sun, Y., Walker, C.M., Lemonnier, F.A., Jacobson, S. and Kaumaya, P.T.P. (2003) Vaccine, 21, 2767-2781.
78. Boykins, R.A., Ardans, J.A., Wahl, L.M., Lal, R.B., Yamada, K.M. and Dhawan, S. (2000) Peptides, 21, 1839-1847.
79. Liao, M., Lu, Y., Xiao, Y., Dierich, M.P. and Chen, Y-H. (2000) Peptides, 21, 463-468.
80. Dong, X-N., Xiao, Y. and Chen, Y-H. (2001) Immunogy Letters, 75, 149-152.
81. Ding, J., Lu, Y. and Chen, Y.H. (2000) FEMS Immunology and Medical Microbiology, 29, 123-127.
82. Joyce, J.G., Hurni, W.M., Bogusky, M.J., Garsky, V.M., Liang, X., Citron, M.P., Danzeisen, R.C., Miller, M.D., Shiver, J.W. and Keller, P.M. (2002) J. Biol. Chem., 277, 45811-45820.
83. Viveros, M., Dickey, C., Cotropia, J.P., Gevorkian, G., Larralde, C., Broliden, K., Levi, M., Burgess, A., Can, C., Weiner, DB., Agadjanyan, M.G. and Ugen, K.E. (2000) Virology, 270, 135-45.
84. Seth, A., Yasutomi, Y., Jacoby, H., Callery, J.C., Kaminsky, S.M., Koff, W.C., Nixon, D.F. and Letvin, N.L. (2000) AIDS Research and Human Retroviruses, 16, 337-343.
85. Pisarev, V.M., Parajuli, P., Mosley, R.L., Sublet, J., Kelsey, L., Sarin, P.S., Zimmerman, D.H., Winship, M.D. and Talmadge, J.E. (2000) Intern. J. Immunopharmacol., 22, 865-876.
86. Asjö, B., Stavang, H., Sorensen, B., Baksaas, I., Nyhus, J. and Langeland, N. (2002) AIDS Research and Human Retroviruses, 18, 1357-1365.
87. Carlos, M.P., Anderson, D.E., Gardner, M.B. and Torres, J.V. (2000) AIDS Research and Human Retroviruses, 16, 153-161.
88. Ahmad, N., Khan, M.A. and Owais, M. (2001) Cel. Immunol., 210, 49-55.
89. Lambert, J.S., Keefer, M., Mulligan, M.J., Schwartz, D., Mestecky, J., Weinhold, K., Smith, C., Hsieh, R., Moldoveanu, Z., Fast, P., Forrest, B. and Koff, W. (2001) Vaccine, 19, 3033-3042.
90. Hewer, R. and Meyer, D. (2003) Mol. Immunol., 40, 327-335.
91. Letvin, N.L., Robinson, S., Rohne, D., Axthelm, M.K., Fanton, J.W., Bilska, M., Palker, T.J., Liao, H-X., Haynes, B.F. and Montefiori, D.C. (2001) J. Virol., 75, 4165-4175.
92. Misumi, S., Takamune, N., Ido, Y., Hayashi, S., Endo, M., Mukai, R., Tachibana, K., Umeda, M. and Shoji, S. (2001) Biochem. Biophys. Res. Commun., 285, 1309-1316.
93. Wang, C.Y., Shen, M., Tam, G., Fang, X.D,, Ye, J., Shen, F., Walfield, A.M., Wang, J.J.G., Li M.L., Li, X.M, Salas, M., Shearer, M.H., Kennedy, R.C. and Hanson, C.V. (2002) Vaccine, 21, 89-97.
94. Arkema, A., Huckriede, A., Schoen, P., Wilschut, J. and Daemen, T. (2000) Vaccine, 18, 1327-1333.
95. Zeng, W., Jackson, D.C., Murray, J., Rose, K. and Brown, L.E. (2000) Vaccine, 18, 1031-1039.
96. Olszewska, W., Obeid, O.E. and Steward, M.W. (2000) Virology, 272, 98-105.
97. Olszewska, W., Partidos, C.D. and Steward, M.W. (2000) Infection and Immunity, 68, 4923-4929.
98. El Kasmi, K.C., Fillo, S., Theisen, D.M., Hartter, H., Brons, N.H.C., Muller, C.P. (2000) J. Gen. Viroi., 81, 729-735.
99. Dong, X.N., Wei, K., Liu, Z.Q. and Chen, Y.H. (2002) Vaccine, 21, 167-173.
100. Wang, C.Y., Chang, T.Y., Walfield, A.M., Ye, J., Shen, M., Chen, S.P., Li, M.C., Lin, Y.L., Jong, M.H., Yang, P.C., Chyr, N., Kramer, E. and Brown, F. (2002) Vaccine, 20, 2603-2610.
101. Rodriguez, L.L., Barrera, J., Kramer, E., Lubroth, J., Brown, F. and Golde, W.T. (2003) Vaccine, 21, 3751-3756.
102. Kawana, K., Kawana, Y., Yoshikawa, H., Taketani, Y., Yoshiike, K. and Kanda, T. (2001) Vaccine, 19, 1496-1502.
103. Embers, M.E., Budgeon, L.R., Pickel, M. and Christensen, N.D. (2002), J. Virol., 76, 9798-9805.
104. Ludewig, B., Barchiesi, F., Pericin, M., Zinkernagel, R.M., Hengartner, H. and Schwendener R.A. (2001) Vaccine, 19, 23-32.
105. Kumaraguru, U., Gierynska, M., Norman, S., Bruce, B.D. and Rouse, B.T. (2002) J. Virol., 76, 136-141.
106. Mezo, G., Dalmadi, B., Mucsi, I., Bosze, S., Rajnavolgyl, E. and Hudecz, F. (2002) J. Pept. Sci., 8, 107-117.